This paper reports on the continuous renal replacement therapy (CRRT) technology group recommendations and research proposals developed during the 17th Acute Dialysis Quality Initiative Meeting in Asiago, Italy. The group was tasked to address questions related to the impact of technology on acute kidney injury management. We discuss technological aspects of the decision to initiate CRRT and the components of the treatment prescription and delivery, the integration of information technology (IT) on overall patient management, the incorporation of CRRT into other ‘non-renal' extracorporeal technologies such as ECMO and ECCO2R and the use of sorbents in sepsis and propose new areas for future research. Instead of reviewing current knowledge, the group focused on developing a renovated research agenda that reflects current and future technological advances, centered on innovations in new equipment, membranes and IT that will permit the integration of patient care and decision-making processes for years to come.

Keywords:
Continuous renal replacement therapy, Technology , Dialysis machine, Electronic medical record, Acute kidney injury, Extracorporeal therapies, Continuous veno-venous hemofiltration, Continuous veno-venous hemodialysis, Continuous veno-venous hemodiafiltration , Hemoperfusion
1.
Ricci Z, Bonello M, Salvatori G, Ratanarat R, Brendolan A, Dan M, et al: Continuous renal replacement technology: from adaptive devices to flexible multipurpose machines. Crit Care Resusc 2004;6:180-187.
2.
Cerdá J, Ronco C: Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial 2009;22:114-122.
3.
Cruz D, Bobek I, Lentini P, Soni S, Chionh CY, Ronco C: Machines for continuous renal replacement therapy. Semin Dial 2009;22:123-132.
4.
Ricci Z, Ronco C: Technical advances in renal replacement therapy. Semin Dial 2011;24:138-141.
5.
Ronco C, Kellum JA, Mehta R: The acute dialysis quality initiative: the New York conference. Adv Ren Replace Ther 2002;9:248-251.
7.
Murray P, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, et al: Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th acute dialysis quality initiative consensus conference. Kidney Int 2014;85:513-521.
8.
McCullough PA, Kellum JA, Haase M, Müller C, Damman K, Murray PT, et al: Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol 2013;182:82-98.
9.
Villa G, Ricci Z, Romagnoli S, Ronco C: Multidimensional approach to adequacy of renal replacement therapy in acute kidney injury. Contrib Nephrol 2016;187:94-105.
10.
Ronco C, Kellum JA, Haase M: Subclinical AKI is still AKI. Crit Care 2012;16:313.
11.
Zaragoza JJ, Villa G, Garzotto F, Sharma A, Lorenzin A, Ribeiro L, et al: Initiation of renal replacement therapy in the intensive care unit in Vicenza (IRRIV) score. Blood Purif 2015;39:246-257.
12.
Lachance P, Villeneuve PM, Wilson FP, Selby NM, Featherstone R, Rewa O, et al: Impact of e-alert for detection of acute kidney injury on processes of care and outcomes: protocol for a systematic review and meta-analysis. BMJ Open 2016;6:e011152.
13.
Ricci Z, Romagnoli S, Villa G, Ronco C: Modality and dosing of acute renal replacement therapy. Minerva Urol Nefrol 2016;68:78-86.
14.
Villa G, Ricci Z, Ronco C: Renal replacement therapy. Crit Care Clin 2015;31:839-848.
15.
Ronco C: Standard nomenclature for renal replacement therapy in acute kidney injury: very much needed! Blood Purif 2014;38:I-II.
16.
Neri M, Cerdà J, Garzotto F, Villa G, Ronco C: Nomenclature for renal replacement therapy in acute kidney injury; in Kellum JA, Bellomo R, and Ronco C (eds): Continuous Renal Replacement Therapy, 2016, pp 21-34.
17.
Neri M, Villa G, Garzotto F, Bagshaw S, Bellomo R, Cerda J, et al: Nomenclature for renal replacement therapy in acute kidney injury: basic principles. Crit Care, in press.
18.
Villa G, Neri M, Bellomo R, Cerda J, De Gaudio R, De Rosa S, et al: Nomenclature for renal replacement therapy in acute kidney injury: practical applications. Crit Care, in press.
19.
Ronco C: The Charta of Vicenza. Blood Purif 2015;40:I-V.
20.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:124-138.
21.
Bagshaw SM, Cruz DN, Gibney RT, Ronco C: A proposed algorithm for initiation of renal replacement therapy in critically ill patients. Crit Care 2009;13:317.
22.
Ostermann M, Dickie H, Barrett NA: Renal replacement therapy in critically ill patients with acute kidney injury - when to start. Nephrol Dial Transplant 2012;27:2242-2248.
23.
Macedo E, Mehta RL: When should renal replacement therapy be initiated for acute kidney injury? 2011;24:132-137.
24.
Macedo E, Mehta RL: Tailored therapy: matching the method to the patient. Blood Purif 2012;34:124-131.
25.
Mehta RL: Indications for dialysis in the ICU: renal replacement vs. renal support. Blood Purif 2001;19:227-232.
26.
Brain MJ, Roodenburg OS, Adams N, McCracken P, Hockings L, Musgrave S, et al: Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the filter life in renal replacement therapy pilot trial. Crit Care Resusc 2014;16:131-137.
27.
Mehta RL: Automated electronic monitoring of circuit pressures during continuous renal replacement therapy: a technical report. Blood Purif 2001;19:227-232.
28.
Kim IB, Fealy N, Baldwin I, Bellomo R: Premature circuit clotting due to likely mechanical failure during continuous renal replacement therapy. Blood Purif 2010;30:79-83.
29.
Dunn WJ, Sriram S: Filter lifespan in critically ill adults receiving continuous renal replacement therapy: the effect of patient and treatment-related variables. Crit Care Resusc 2014;16:225-231.
30.
Rewa O, Mottes T, Bagshaw SM: Quality measures for acute kidney injury and continuous renal replacement therapy. Curr Opin Crit Care 2015;21:490-499.
31.
Ronco C: Fluid balance in CRRT: a call to attention! Int J Artif Organs 2005;28:763-764.
32.
Bagshaw SM, Baldwin I, Fealy N, Bellomo R: Fluid balance error in continuous renal replacement therapy: a technical note. Int J Artif Organs 2007;30:434-440.
33.
Bouchard J, Soroko SB Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, et al: Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009;76:422-427.
34.
Rewa O, Villeneuve PM, Eurich DT, Stelfox HT, Gibney RT, Hartling L, et al: Quality indicators in continuous renal replacement therapy (CRRT) care in critically ill patients: protocol for a systematic review. Syst Rev 2015;4:102.
35.
Graham P, Lischer E: Nursing issues in renal replacement therapy: organization, manpower assessment, competency evaluation and quality improvement processes. Semin Dial 2011;24:183-187.
36.
Sutherland SM, Goldstein SL, Alexander SR: The prospective pediatric continuous renal replacement therapy (ppCRRT) registry: a critical appraisal. Pediatr Nephrol 2014;29:2069-2076.
37.
Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, et al: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-3587.
38.
Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, et al: Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 2005;9:R294-R302.
39.
Joannes-Boyau O, Honoré PM, Perez P, Bagshaw SM, Grand H, Canivet JL, et al: High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 2013;39:1535-1546.
40.
Zhang P, Yang Y, Lv R, Zhang Y, Xie W, Chen J: Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transplant 2012;27:967-973.
41.
Clark E, Molnar AO, Joannes-Boyau O, Honoré PM, Sikora L, Bagshaw SM: High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care 2014;18:R7.
42.
Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, et al: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007;11:R47.
43.
Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, et al: Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445-2452.
44.
Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al: Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 2015;41:975-984.
45.
Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, et al: Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006;34:2099-2104.
46.
Honoré PM, Jacobs R, Boer W, Joannes-Boyau O, De Regt J, De Waele E, et al: New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury. Blood Purif 2012;33:44-51.
47.
Taniguchi T: Cytokine adsorbing columns 2010;166:134-141.
48.
Peng ZY, Carter MJ, Kellum JA: Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med 2008;36:1573-1577.
49.
Quintel M: CytoSorb™ Whole Blood Cytokine Adsorption - Results of a Controlled Randomized Trial. Brussels, 32nd International Symposiumon Intensive Care and Emergency Medicine, 2012.
50.
Combes A, Brodie D, Bartlett R, Brochard L, Brower R, Conrad S, et al: Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 2014;190:488-496.
51.
Jacobs R, Honore PM, Spapen HD: Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense? Crit Care 2015;19:145.
52.
Terragni P, Maiolo G, Ranieri VM: Role and potentials of low-flow CO(2) removal system in mechanical ventilation. Curr Opin Crit Care 2012;18:93-98.
53.
Yamashita A, Masaki H, Kobayashi E, Sukegawa T: Evaluation of solute penetration across the polysulfone membrane with vitamin E coating. Hemodial Int 2015;19(suppl 3):S20-S25.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.